Anthropic acquired Stainless, the SDK compiler behind OpenAI, Gemini and Llama. The deal hands one AI lab structural leverage ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. OpenAI wants you to know how good its latest image generator is —and it has a few fake screenshots and ...
Hosted on MSN
Iran unlikely to open Hormuz if it can't generate revenue – but that's achievable: Analyst
Samir Kapadia, Managing Principal at Vogel Group, says the first issue that needs to be addressed on the Strait of Hormuz is whether Iran can make revenue from it, as it wants a 'sanctions shield' to ...
OpenAI is developing a "super app" for desktop that unifies ChatGPT, its browser and its Codex app, according to the Wall Street Journal and CNBC. A company spokesperson told the publications that ...
OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...
With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...
Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...
Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...
Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Somerville company aims to ...
Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results